Trials / Unknown
UnknownNCT01430377
Side Branch Predilatation Strategy in Coronary Bifurcation Lesion Stenting (SBPS)
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Medica Cor Heart Hospital · Academic / Other
- Sex
- All
- Age
- 20 Years – 90 Years
- Healthy volunteers
- Not accepted
Summary
The role of Side Branch (SB) predilatation during coronary bifurcation lesion percutaneous coronary intervention (PCI) is still not established. The predilatation could potentially damage SB ostium by vessel dissection, making subsequent wiring problematic. However, predilatation could eliminate SB ostial stenosis obviating need for further SB treatment after main vessel stent implantation. The aim of the study is to assess in random fashion the periprocedural myonecrosis, complication rates and time for SB rewiring in groups with and without SB predilatation.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | SB predilatation | Initial SB \[predilatation. |
| PROCEDURE | No SB predilatation | Without SB predilatation |
Timeline
- Start date
- 2011-08-01
- Primary completion
- 2012-04-01
- Completion
- 2012-05-01
- First posted
- 2011-09-08
- Last updated
- 2011-09-08
Locations
1 site across 1 country: Bulgaria
Source: ClinicalTrials.gov record NCT01430377. Inclusion in this directory is not an endorsement.